Sarepta, a biotech best known for its development of gene therapies, has for years been quietly exploring gene editing as well, and on Tuesday revealed a partnership with a South San Francisco startup that's been in place since December 2020.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,